{"id":30058,"date":"2025-02-19T14:06:38","date_gmt":"2025-02-19T13:06:38","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=30058"},"modified":"2025-02-19T14:06:40","modified_gmt":"2025-02-19T13:06:40","slug":"appel-a-projets-messidore-2025","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/","title":{"rendered":"Appel \u00e0 Projets MESSIDORE 2025"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

L\u2019IReSP lance la nouvelle \u00e9dition de MESSIDORE, <\/strong>un appel \u00e0 projets (AAP) de l\u2019Inserm, gr\u00e2ce au soutien renouvel\u00e9 du Minist\u00e8re du travail, de la sant\u00e9, des solidarit\u00e9s et des familles, dans le cadre du Programme strat\u00e9gique de recherche collaborative en sant\u00e9.<\/p>\n\n\n\n

Cet AAP a pour objectif de soutenir des projets collaboratifs entre \u00e9quipes de recherche (dont au moins une sous tutelle Inserm) et des offreurs de soins sur les 2 axes suivants :<\/p>\n\n\n\n

Axe 1<\/strong> : Essais cliniques innovants, essais en soins primaires et dispositifs m\u00e9dicaux<\/p>\n\n\n\n

Axe 2<\/strong> : \u00c9tudes exploitant des donn\u00e9es de sant\u00e9 ou reposant sur l’exploitation de biobanques.<\/p>\n\n\n\n

Les candidatures (lettre d\u2019intention) sont attendues avant le vendredi 11 avril 2025 \u00e0 midi (heure de Paris) au plus tard.<\/strong><\/p>\n\n\n\n

Informations essentielles :<\/p>\n\n\n\n

D\u00e9p\u00f4t des candidatures exclusivement via la plateforme EVA3 <\/strong>: https:\/\/www.eva3.inserm.fr\/login<\/a><\/p>\n\n\n\n

\u00c9ligibilit\u00e9<\/strong> : Les projets pouvant b\u00e9n\u00e9ficier d’un financement par d’autres programmes (Minist\u00e8re du travail, de la sant\u00e9, des solidarit\u00e9s et des familles<\/a>, INCa, ANRS-MIE, IReSP sur les addictions) ne sont pas \u00e9ligibles.<\/p>\n\n\n\n

L’\u00e9dition 2025 de l’AAP MESSIDORE adopte une proc\u00e9dure en deux phases<\/strong> :<\/p>\n\n\n\n

1\ufe0f. Phase de pr\u00e9s\u00e9lection<\/strong> : \u00e9valuation des lettres d’intention ;
2\ufe0f. Phase de s\u00e9lection finale<\/strong> : \u00e9valuation des dossiers complets pour les projets retenus \u00e0 l’issue de la premi\u00e8re phase.<\/p>\n\n\n\n

\ud83d\udce9 Contacts pour toute information compl\u00e9mentaire :<\/p>\n\n\n\n

Aspects scientifiques et administratifs : messidore@inserm.fr<\/a>
Aspects techniques relatifs \u00e0 la plateforme de d\u00e9p\u00f4t des candidatures EVA3 : eva@inserm.fr<\/a><\/p>\n\n\n\n

\ud83d\udc49 Retrouvez toutes les informations sur notre site internet : https:\/\/iresp.net\/appel_a_projets\/appel-a-projets-messidore-2025-methodologie-des-essais-cliniques-innovants-dispositifs-outils-et-recherches-exploitant-les-donnees-de-sante-et-biobanques\/<\/a><\/p>\n\n\n\n

N\u2019h\u00e9sitez pas \u00e0 diffuser largement cette information aupr\u00e8s des personnes susceptibles d\u2019\u00eatre int\u00e9ress\u00e9es.<\/p>\n","protected":false},"excerpt":{"rendered":"

L\u2019IReSP lance la nouvelle \u00e9dition de MESSIDORE, un appel \u00e0 projets (AAP) de l\u2019Inserm, gr\u00e2ce au soutien renouvel\u00e9 du Minist\u00e8re du travail, de la sant\u00e9, des solidarit\u00e9s et des familles, dans le cadre du Programme strat\u00e9gique de recherche collaborative en sant\u00e9. Cet AAP a pour objectif de soutenir des projets collaboratifs entre \u00e9quipes de recherche […]<\/p>\n","protected":false},"author":280,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[38],"tags":[6629],"acf":[],"yoast_head":"\nAppel \u00e0 Projets MESSIDORE 2025 - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Appel \u00e0 Projets MESSIDORE 2025 - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T13:06:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-19T13:06:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png\" \/>\n<meta name=\"author\" content=\"Kevin Gr\u00e9goire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kevin Gr\u00e9goire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/\"},\"author\":{\"name\":\"Kevin Gr\u00e9goire\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\"},\"headline\":\"Appel \u00e0 Projets MESSIDORE 2025\",\"datePublished\":\"2025-02-19T13:06:38+00:00\",\"dateModified\":\"2025-02-19T13:06:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/\"},\"wordCount\":280,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png\",\"keywords\":[\"AAP\"],\"articleSection\":[\"Appels \u00e0 projets\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/\",\"name\":\"Appel \u00e0 Projets MESSIDORE 2025 - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png\",\"datePublished\":\"2025-02-19T13:06:38+00:00\",\"dateModified\":\"2025-02-19T13:06:40+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Appels \u00e0 projets\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Appel \u00e0 Projets MESSIDORE 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\",\"name\":\"Kevin Gr\u00e9goire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Appel \u00e0 Projets MESSIDORE 2025 - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/","og_locale":"fr_FR","og_type":"article","og_title":"Appel \u00e0 Projets MESSIDORE 2025 - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2025-02-19T13:06:38+00:00","article_modified_time":"2025-02-19T13:06:40+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png"}],"author":"Kevin Gr\u00e9goire","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Kevin Gr\u00e9goire","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/"},"author":{"name":"Kevin Gr\u00e9goire","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700"},"headline":"Appel \u00e0 Projets MESSIDORE 2025","datePublished":"2025-02-19T13:06:38+00:00","dateModified":"2025-02-19T13:06:40+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/"},"wordCount":280,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png","keywords":["AAP"],"articleSection":["Appels \u00e0 projets"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/","name":"Appel \u00e0 Projets MESSIDORE 2025 - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png","datePublished":"2025-02-19T13:06:38+00:00","dateModified":"2025-02-19T13:06:40+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-2.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/appel-a-projets-messidore-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Appels \u00e0 projets","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/appels-a-projets\/"},{"@type":"ListItem","position":4,"name":"Appel \u00e0 Projets MESSIDORE 2025"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700","name":"Kevin Gr\u00e9goire"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-13 18:36:41","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30058"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/280"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=30058"}],"version-history":[{"count":3,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30058\/revisions"}],"predecessor-version":[{"id":30063,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30058\/revisions\/30063"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=30058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=30058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=30058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}